The 2024 AUA Annual Meeting is reported in advance!45 Chinese studies have been selected for the podium conference, and the results are remarkable!

The annual meeting of the American Urological Association (AUA), an annual global urology event, will be held in San Antonio, USA from May 3 to May 6 local time. As the world's largest and most influential urology conference, the AUA Annual Meeting brings together pioneering research, new guidelines and the latest advances in urology from around the world. The abstracts of the 2024 AUA Annual Meeting were released yesterday, and we are pleased to witness that more and more China studies are making a strong voice at international conferences. According to the statistics of Yimaitong, a total of 45 Chinese studies have been selected for Podium (podium conference), a three-fold increase from last year (13 projects)!

PART.015/03

Prostate Cancer: Advanced (Including Medications) I.

01摘要号：PD01-09

标题：A PROSPECTIVE COHORT STUDY COMPARING THE EFFICACYOF NEOADJUVANT ABITREXONED/- DOCETAXEL AND RADICALPROSTATECTOMY IN LOCALLY ADVANCED PROSTATE CANCER

第一作者:Xuan Wang

Bladder cancer: invasive I

02摘要号：PD02-10

标题：EVALUATING THE DIAGNOSTIC PERFORMANCE OFBIPARAMETRIC MAGNETIC RESONANCE IMAGING ANDMULTIPARAMETRIC MAGNETIC RESONANCE IMAGING INMUSCLE-INVASIVE BLADDER CANCER

First Author: Qiang Lyu

03摘要号：PD02-11

标题：UNLOCKING THE POWER OF MRI: DEEP LEARNING FORASSESSMENT OF MUSCLE-INVASIVE BLADDER CANCER INVI-RADS 3

First Author: Qiang Lyu

Benign prostatic hyperplasia: basic research and pathophysiology

04摘要号：PD03-11

标题：POLYGENIC RISK SCORE PREDICTING SUSCEPTIBILITY ANDOUTCOME OF BENIGN PROSTATIC HYPERPLASIA IN THE HANCHINESE

First Author:Po-Yen Hsieh (Taiwan, China)

Prostate Cancer: Basic Research & Pathophysiology II.

05摘要号：PD09-01

标题：REGULATORY EFFECTS OF MIR-21 ON THE PROSTATE WITH ORWITHOUT TUMOR-BEARING CONDITIONS: A NOVELPERSPECTIVE BASED ON EXTRACELLULAR VESICLES

First Author: Cong Hu

06摘要号：PD09-12

标题：UNLOCKING THE POTENTIAL OF SPERMINE: TARGETINGHMOX1-INDUCED MITOPHAGY IN PROSTATE CANCER THERAPY

First Author:Jingkai Sun (Hong Kong, China)

Bladder Cancer: Basic Research & Pathophysiology II.

07摘要号：PD14-03

标题：BLADDER CANCER ORGANOIDS SERVE AS A USEFUL SYSTEMTO MIRROR THE CHARACTERISTICS OF PARENTAL TUMOURS

First Author:Hongda Zhao (Hong Kong, China)

08摘要号：PD14-06

标题：TARGETING LASS2: A NEW WAY OUT FOR CHEMORESISTANTBLADDER CANCER

First Author: Shi Fu

09摘要号：PD14-08

标题：IDENTIFICATION OF A BLADDER CANCER SUBPOPULATIONTHAT MAY BENEFIT FROM DASATINIB

First Author: Shi Fu

010摘要号：PD14-09

标题：HIGH AND SELECTIVE CYTOTOXICITY OFEX VIVOEXPANDEDALLOGENEIC HUMAN NATURAL KILLER CELLS FROMPERIPHERAL BLOOD AGAINST BLADDER CANCER:IMPLICATIONS FOR NATURAL KILLER CELL INSTILLATIONAFTER TRANSURETHRAL RESECTION OF BLADDER TUMOR

第一作者:Fangming Wang

Kidney Cancer: Basic Research and Pathophysiology I.

011摘要号：PD16-07

标题：MOLECULAR MECHANISMS OF CLDN10-ATP5O REGULATION OFMITOCHONDRIAL OXIDATIVE PHOSPHORYLATION TO INHIBITRENAL CELL CARCINOMA METASTASIS

第一作者:Yanqing Gong

PART.025/4

Kidney Cancer: Advanced (including drug therapy) II.

012摘要号：PD18-02

标题：NEUTROPHIL EXTRACELLULAR TRAPS IN RELATIONSHIP TOEFFICACY OF SYSTEMIC THERAPY FOR METASTATIC RENALCELL CARCINOMA

第一作者:Ruiyang Xie

膀胱癌：上尿路移行细胞癌Ⅰ

013摘要号：PD20-11

标题：NEOADJUVANT TORIPALIMAB AND CHEMOTHERAPY FORLOCALLY ADVANCED UPPER URINARY TRACT CARCINOMA: APILOT STUDY FOR A PHASE II TRIAL

First Author: Xinyang Liao

014摘要号：PD20-12

标题：NEOADJUVANT THERAPY IN INITIALLY INOPERABLE UPPERTRACT UROTHELIAL CARCINOMAdA COMPARATIVE STUDYWITH ADJUVANT STRATEGIES

First Author:Yu-Kai Huang (Taiwan, China)

Reconstruction: Reinforcement, substitution, diversion

015摘要号：PD21-09

标题：HEALTH-RELATED QUALITY OF LIFE IN PATIENTS UNDERGOINGILEAL URETER REPLACEMENT FOR EXTENSIVE URETERALSTRICTURE: A MULTI-INSTITUTIONAL PROSPECTIVE STUDY

第一作者:Xiang Wang

adrenal gland

016摘要号：PD23-03

标题：ROLE OF 68GA-PENTIXAFOR PET/CT TARGETING CXCR4 INASSISTING THE SURGICAL STRATEGY OF PRIMARYALDOSTERONISM

First author: Guoyang Zhen

Genitourinary tract infection/inflammation/cystic disease: interstitial cystitis

017摘要号：PD25-10

标题：INTRAVESICAL INSTILLATION OF EPIDERMAL GROWTH FACTORCOULD LESSEN THE INFLAMMATION AND AMELIORATE THEOXIDATIVE STRESS IN RATS WITH LPS-INDUCED INTERSTITIALCYSTITIS

First Author:Che-Hsueh Yang (Taiwan, China)

Reconstruction: External Genitalia and Urology (including transgender surgery and traumatic fistula) I.

018摘要号：PD31-09

标题：SURGICAL STRATEGY AND OUTCOMES OF PENOSCROTALPAGET'S DISEASE: A LARGE RETROSPECTIVE COHORT STUDYIN A CHINESE TERTIARY CENTER

First Author: Xiang Wan

Bladder Cancer: Non-Invasive II.

019摘要号：PD30-12

标题：A PROSPECTIVE STUDY ON THE IMPACT OF CONTINUOUSSALINE BLADDER IRRIGATION AFTER TRANSURETHRALRESECTION OF BLADDER TUMOR ON TUMOR CELLDISSEMINATION

The 30-day-a-day trip to the using the 1000-day-a-day trip to the using the 1000-day-a-day trip to the using the I-5000 in 2015.

Limited Limit: Surgical Treatment II.

020摘要号：PD33-07

标题：NEOADJUVANT TORIPALIMAB COMBINED WITH AXITINIB INPATIENTS WITH LOCALLY ADVANCED CLEAR CELL RENAL CELLCARCINOMA: A SINGLE-ARM, PHASE II TRIAL

First Author: Jiwei Huang

Prostate Cancer: Basic Research and Pathophysiology III.

021摘要号：PD35-01

标题：NEURONAL CIRCUITRY ORCHESTRATES DISEASEPROGRESSION IN PROSTATE CANCER

First Author: Le Li

022摘要号：PD35-02

标题：CBP-1018, A DUAL-LIGAND DRUG TARGETING PSMA-FOLR1, ISAVAILABLE FOR PROSTATE CANCER TREATMENT AND HAS THEPOTENTIAL TO BE USED IN COMBINATION WITH OTHERTHERAPIES

第一作者:Ruilin Zhuang

023摘要号：PD35-05

标题：M2-LIKE MACROPHAGE PROMOTES PROSTATE CANCERMETASTASIS BY HORIZONTAL TRANSFER OF TXNDC5 MRNA VIAEXTRACELLULAR VESICLES

First Author: Cong Hu

024摘要号：PD35-08

标题：INITIAL VALIDATION OF18F-FDOPA PET IMAGING FORNONINVASIVE DETECTION OF NEUROENDOCRINE PROSTATECANCER

第一作者:Bing Guan

PART.035/05

膀胱癌：上尿路移行细胞癌Ⅲ

025摘要号：PD41-04

标题：DENSITY OF CD163+TUMOR-ASSOCIATED MACROPHAGEINFILTRATION PREDICTS PROGNOSIS OF UPPER TRACTUROTHELIAL CARCINOMA PATIENTS AFTER RADICAL NEPHROURETERECTOMY

First Author:Shang Yuan Hsu (Taiwan, China)

026摘要号：PD41-05

标题：MIR-299-3P INHIBITS CELL PROLIFERATION, MIGRATION,INVASION AND ANGIOGENESIS THROUGH VEGFA IN UPPERTRACT UROTHELIAL CARCINOMA

First Author:Wei-Chi Hsu (Taiwan, China)

Prostate Cancer: Marker II.

027摘要号：PD42-10

标题：IMMUNOSUPPRESSIVE ROLE OF BDNF IN THERAPY-INDUCEDNEUROENDOCRINE PROSTATE CANCER

First Author:Yu-Tsan Lin (Taiwan)

028摘要号：PD42-09

标题：NAVIGATING ANTIBODY-DRUG CONJUGATE TARGETSEXPRESSION PROFILES ACROSS DIVERSE PROSTATE CANCERTYPES

第一作者:Yelin Mulati

029摘要号：PD42-02

标题：PSMA PET/CT RADIOMICS: ASSESSING ADVERSEPATHOLOGICAL RISK AND PROTEOMIC BIOMARKERCORRELATIONS IN PROSTATE CANCER

First Author: Wenhao Zhu

Urodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medications: Overactive Bladder I.

030摘要号：PD43-03

标题：ELEVATED SKIN SYMPATHETIC NERVE ACTIVITY AS APREDICTOR OF ORAL MONOTHERAPY REFRACTORINESS INOVERACTIVE BLADDER

First Author:Yu-Chen Chen (Taiwan, China)

031摘要号：PD43-04

标题：ENHANCING UROLOGICAL DIAGNOSTICS: SYNERGISTICAPPROACH WITH URINE BIOMARKERS AND SKIN SYMPATHETICNERVE ACTIVITY FOR URGE URINARY INCONTINENCE

First Author:Yu-Chen Chen (Taiwan, China)

Reconstruction: ureteral reconstruction (including pyeloplasty) and bladder reconstruction (including trauma-related fistula) II.

032摘要号：PD44-03

标题：COMPARATIVE EFFECTIVENESS OF SURGICAL TREATMENTSFOR RECURRENT OBSTRUCTION FOLLOWING PYELOPLASTY: AMULTICENTER, PROSPECTIVE STUDY

First Author: Shengwei Xiong

033摘要号：PD44-02

标题：MACHINE LEARNING ALGORITHMS FOR PREDICTING THERECURRENCE OF OBSTRUCTION AFTER PYELOPLASTY: AMULTICENTER RETROSPECTIVE STUDY

First Author: Shengwei Xiong

Calculous lesions: Surgical treatment (including Eswl)IV.

034摘要号：PD47-07

标题：THE STUDY OF AUTOMATIC RECOGNITION OF STONECOMPONENTS USING DIGITAL IMAGES FROM INTRAOPERATIVEFLEXIBLE URETEROSCOPY

First Author: Daxun Luo

Bladder Cancer: Non-Invasive III.

035摘要号：PD48-06

标题：URINE CELLULAR DNA METHYLATION AND MUTATION TEST FORDETECTING UROTHELIAL CARCINOMA

First Author: Yucai Wu

Kidney Cancer: Basic Research & Pathophysiology II.

036摘要号：PD51-01

标题：PLASMA TSRNAS AS NOVEL DIAGNOSTIC BIOMARKERS FORRENAL CELL CARCINOMA

第一作者:Meng Ding

037摘要号：PD51-11

标题：ICARSIDE II AND SUNITINIB COOPERATIVELY INDUCEAPOPTOSIS OF RENAL CELL CARCINOMA CELLS VIAACTIVATING THE ATF4/NOXA AXIS AND INHIBITING THEPI3K/AKT PATHWAY

First Author: Yu Ren

PART.045/6

Infertility: Basic Research & Pathophysiology

038摘要号：PD53-09

标题：ABERRANT GENE EXPRESSION PROFILING IN MEN WITHSERTOLI CELL-ONLY SYNDROME

第一作者:Ninghong Song

039摘要号：PD53-10

标题：MOLECULAR MECHANISM OF VDAC2 PROTEIN REGULATION OFSPERM MOTILITY PROBED BY TRANS-TESTICULAR MESHMICROINJECTION TECHNIQUE

第一作者:Zengjun Wang

040摘要号：PD53-11

标题：DEFEROXAMINE MESYLATE HAS THE POTENTIAL TO RESCUETHE DECLINE IN SPERM QUALITY CAUSED BYADENINE-INDUCED CHRONIC KIDNEY DISEASE

First Author:YiKai Chang (Taiwan, China)

Urodynamics/Lower Urinary Tract Dysfunction/Pelvic Medications in Women: Overactive Bladder II.

041摘要号：PD54-10

标题：ENURESIS IN OVERACTIVE BLADDER-WET WOMEN: THE RISKFACTORS, URODYNAMIC FEATURES, AND ASSOCIATION WITHDISTRESS

First Author:Kuan Chong Ng (Taiwan, China)

Transplant and Vascular Surgery II.

042摘要号：PD56-06

标题：INDOCYANINE GREEN FLUORESCENCE FOR PREVENTINGEARLY URETERAL COMPLICATIONS IN KIDNEYTRANSPLANTATION: PROCEDURAL FLOWCHART AND CLINICALOUTCOMES

First Author:Shang Yuan Hsu (Taiwan, China)

Urodynamics/lower urinary tract dysfunction/pelvic medications in women: neuromodulation

043摘要号：PD59-03

标题：REMOTE PROGRAMMING IN PHASE I SACRALNEUROMODULATION: A MULTI-CENTER FEASIBILITY STUDY

第一作者:Lingfeng Meng

044摘要号：PD59-02

标题：EFFICACY AND SAFETY OF VARIABLE FREQUENCYSTIMULATION VERSUS CONSTANT FREQUENCY STIMULATIONIN SACRAL NEUROMODULATION FOR REFRACTORY LOWERURINARY TRACT DYSFUNCTION: A MULTICENTER,PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, CROSSOVERSTUDY IN CHINA

第一作者:Lingfeng Meng

Genitourinary Tract Infection/Inflammation/Cystic Disease: Kidney and Bladder II.

045摘要号：PD63-05

标题：DECODING THE INTRICACIES OF CHRONIC KIDNEY DISEASE:EXPLORING GTF21 POLYMORPHISMS AS POTENTIALBIOMARKERS IN A COLLABORATIVE MULTICENTRICCROSS-SECTIONAL STUDY

First Author:Kevin Lu (Taiwan)

Note: The ranking is in no particular order, if there is any omission or any questions, please leave us a message~

Resources:

https://www.auajournals.org/toc/juro/211/5S#

编辑:Gardenia审校:Gardenia执行:Gardenia

This platform aims to deliver more medical information to healthcare professionals. The content published on this platform should not be used as a substitute for professional medical guidance in any way, nor should it be regarded as diagnosis and treatment advice. If such information is used for purposes other than understanding medical information, the platform does not assume relevant responsibilities. This platform does not mean that it agrees with its descriptions and views on the published content. If copyright issues are involved, please contact us, and we will deal with it as soon as possible.

Yimaitong is a professional online doctor platform, and the mission of the platform is to "sense the pulse of the world's medicine and help China's clinical decision-making". Yimaitong has a series of products such as "Clinical Guidelines", "Medication Reference", "Medical Literature King", "Yizhiyuan", "eYantong" and "ePulse", which fully meet the needs of medical workers in clinical decision-making, obtaining new knowledge and improving scientific research efficiency.